BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Silexion Therapeutics Corp. (NASDAQ:SLXN)

1 post

Biotech NewsSilexion Therapeutics (SLXN) Targets KRAS Mutation Market Worth $5.8B—Here’s Why Investors Are Watching Closely

  • BioTech Health X
  • November 26, 2025
Silexion Therapeutics Corp. (NASDAQ:SLXN) is a clinical-stage, oncology-focused biotechnology company built on a clear mission: to develop transformative,…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • This Robot Doesn’t Make Coffee — It Makes Hospitals Billions: Intuitive Surgical (ISRG)
  • Soleno Therapeutics (SLNO) Might Be Building Something Bigger Than Most Investors Realize
  • This Biotech Stock Doesn’t Make Drugs — It Makes Money From Them: Ligand Pharmaceuticals (LGND)
  • Why Is Travere Therapeutics (TVTX) Suddenly Popping Up in Investor Searches?
  • Here’s Why Structure Therapeutics (GPCR) Suddenly Become a Hot Biotech Stock
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • January 13, 2026
    This Robot Doesn’t Make Coffee — It Makes Hospitals Billions: Intuitive Surgical (ISRG)
    • January 13, 2026
    Soleno Therapeutics (SLNO) Might Be Building Something Bigger Than Most Investors Realize
    • January 13, 2026
    This Biotech Stock Doesn’t Make Drugs — It Makes Money From Them: Ligand Pharmaceuticals (LGND)
    • January 13, 2026
    Why Is Travere Therapeutics (TVTX) Suddenly Popping Up in Investor Searches?
    • January 13, 2026
    Here’s Why Structure Therapeutics (GPCR) Suddenly Become a Hot Biotech Stock
Recent Posts
  • TG Therapeutics (TGTX) Could Be a Big Winner — or a Big Disappointment
    • January 13, 2026
  • This Biotech Stock Is Targeting Obesity — And That Might Be Its Biggest Advantage: Viking Therapeutics (VKTX)
    • January 13, 2026
  • Why Novavax (NVAX) Is Trending Again — And It’s Not About COVID
    • January 13, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (707)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top